Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Näytä muut versiot (1)

BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 mo...

Bibliografiset tiedot
Päätekijät:	Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Kibwana, E, Parks, H, Ford, K, Dull, P, Pollard, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2013

Samankaltaisia teoksia

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
Tekijä: Blanchard-Rohner, G, et al.
Julkaistu: (2013)

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
Tekijä: Marzia Monica Giuliani, et al.
Julkaistu: (2021-05-01)

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.
Tekijä: Blanchard-Rohner, G, et al.
Julkaistu: (2013)

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age
Tekijä: Blanchard-Rohner, G, et al.
Julkaistu: (2013)

Neisseria meningitidis Serogroup W135, China
Tekijä: Zhujun Shao, et al.
Julkaistu: (2010-02-01)

Pericarditis due to Neisseria meningitidis serogroup W135
Tekijä: Takashi Shinha, et al.
Julkaistu: (2018-01-01)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
Tekijä: Pascal Boisier, et al.
Julkaistu: (2006-09-01)

Hajj-Related Neisseria Meningitidis Serogroup W135 in Mauritius
Tekijä: Mohammad Iqbal Issack, et al.
Julkaistu: (2002-03-01)

Increase in Neisseria meningitidis Serogroup W135, Niger, 2010
Tekijä: Jean-Marc Collard, et al.
Julkaistu: (2010-09-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
Tekijä: Hoan Jong Lee, et al.
Julkaistu: (2014-11-01)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
Tekijä: Muhamed-Kheir Taha, et al.
Julkaistu: (2013-06-01)

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
Tekijä: Katharina Schley, et al.
Julkaistu: (2023-05-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
Tekijä: Lidia Serra, et al.
Julkaistu: (2021-07-01)

Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex
Tekijä: Tanja Popovic, et al.
Julkaistu: (2000-08-01)

Real-world impact and effectiveness of MenACWY-TT
Tekijä: Rodolfo Villena, et al.
Julkaistu: (2023-08-01)

Towards an improved serogroup B Neisseria meningitidis vaccine.
Tekijä: Perrett, K, et al.
Julkaistu: (2005)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
Tekijä: Khatami, A, et al.
Julkaistu: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
Tekijä: Khatami, A, et al.
Julkaistu: (2012)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Tekijä: Carr, JP, et al.
Julkaistu: (2022)

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
Tekijä: Suzanne Chanteau, et al.
Julkaistu: (2006-09-01)

Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, Cameroon
Tekijä: Marie-Christine Fonkoua, et al.
Julkaistu: (2002-03-01)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
Tekijä: María Gabriela Graña, et al.
Julkaistu: (2021-12-01)

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
Tekijä: Andrews, S, et al.
Julkaistu: (2014)

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
Tekijä: Andrews, S, et al.
Julkaistu: (2014)

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
Tekijä: Xie, O, et al.
Julkaistu: (2012)

Neisseria meningitidis W135, Turkey
Tekijä: Levent Doganci, et al.
Julkaistu: (2004-05-01)

Neisseria meningitidis Strain of Unknown Serogroup, China
Tekijä: Haijian Zhou, et al.
Julkaistu: (2011-03-01)

Neisseria meningitidis Serogroup W135 Sequence Type 11, Anhui Province, China, 2011–2013
Tekijä: Shoukui Hu, et al.
Julkaistu: (2014-07-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
Tekijä: Cynthia Burman, et al.
Julkaistu: (2024-12-01)

A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
Tekijä: Jacopo Enotarpi, et al.
Julkaistu: (2020-09-01)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
Tekijä: Timo Vesikari, et al.
Julkaistu: (2020-06-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
Tekijä: David E Barroso, et al.
Julkaistu: (2007-09-01)

Characterization of Unusual Serogroups of <i>Neisseria meningitidis</i>
Tekijä: Samy Taha, et al.
Julkaistu: (2024-12-01)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
Tekijä: Jacob Strahilevitz, et al.
Julkaistu: (2008-10-01)

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
Tekijä: Valerian B Pinto, et al.
Julkaistu: (2013-01-01)

Neisseria meningitidis Serogroup W, Burkina Faso, 2012
Tekijä: Jessica R. MacNeil, et al.
Julkaistu: (2014-03-01)

Spread of Neisseria meningitidis Serogroup W Clone, China
Tekijä: Haijian Zhou, et al.
Julkaistu: (2013-09-01)

Neisseria meningitidis Serogroup X in Sub-Saharan Africa
Tekijä: Alain Agnememel, et al.
Julkaistu: (2016-04-01)

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.
Tekijä: Ivano de Filippis, et al.
Julkaistu: (2012-01-01)

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Tekijä: J. M. Kemmeren, et al.
Julkaistu: (2021-09-01)